Severe Acute Respiratory Syndrome Coronavirus-2 Pneumonia in a Newborn Treated With Remdesivir and Coronavirus Disease 2019 Convalescent Plasma

Abstract Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel pandemic virus. Mounting evidence supports the possibility of vertical transmission, which at the present time appears to be rare. We report a newborn with vertically acquired SARS-CoV-2 who developed acute respiratory...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the Pediatric Infectious Diseases Society 2021-05, Vol.10 (5), p.691-694
Main Authors: Hopwood, Andrew J, Jordan-Villegas, Alejandro, Gutierrez, Liliana D, Cowart, Mallory C, Vega-Montalvo, Wilfredo, Cheung, Wang Leung, McMahan, Michael J, Gomez, Michael R, Laham, Federico R
Format: Article
Language:English
Subjects:
Case Report
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel pandemic virus. Mounting evidence supports the possibility of vertical transmission, which at the present time appears to be rare. We report a newborn with vertically acquired SARS-CoV-2 who developed acute respiratory failure and received remdesivir and coronavirus disease 2019 convalescent plasma. There is growing evidence to support the possibility of vertical transmission of severe acute respiratory syndrome coronavirus 2 (SAR-CoV-2). For those neonates who have coronavirus disease 2019 (COVID-19), there is little evidence to guide treatment. We report a neonate with vertically acquired SARS-CoV-2 who developed acute respiratory failure and received remdesivir and COVID-19 convalescent plasma.
ISSN:2048-7207
2048-7193
2048-7207
DOI:10.1093/jpids/piaa165